PQ 871
871. Deputy Clare Daly asked the Minister for Health further to Parliamentary Question No. 611 of 11 April 2017, the reason Pandemrix continued to be used after 2009 when the Irish Medicines Board was in possession of facts that showed it had a far greater likelihood of adverse reactions. [19463/17]
Introduced
2 May 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
2 May 2017
Summary
871. Deputy Clare Daly asked the Minister for Health further to Parliamentary Question No. 611 of 11 April 2017, the reason Pandemrix continued to be used after 2009 when the Irish Medicines Board was in possession of facts that showed it had a far greater likelihood of adverse reactions. [19463/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Vaccination Programme
Vaccination Programme
xml · EN · 2 May 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-05-02/871/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-05-02/pq_871